<--- Back to Details
First PageDocument Content
Immunosuppressants / Cell signaling / Amgen / Etanercept / Drug design / Drug action / Rheumatoid arthritis / Receptor / Tumor necrosis factor receptor / Biology / Pharmacology / Cell biology
Date: 2012-04-30 03:35:32
Immunosuppressants
Cell signaling
Amgen
Etanercept
Drug design
Drug action
Rheumatoid arthritis
Receptor
Tumor necrosis factor receptor
Biology
Pharmacology
Cell biology

CALIFORNIA STATE SCIENCE FAIR 2012 PROJECT SUMMARY Name(s) Project Number

Add to Reading List

Source URL: www.usc.edu

Download Document from Source Website

File Size: 14,09 KB

Share Document on Facebook

Similar Documents

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first large­scale acquisition since becoming a pure­play life sciences company, Bayer has raised its all­c

July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first large­scale acquisition since becoming a pure­play life sciences company, Bayer has raised its all­c

DocID: 1qiCw - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qius - View Document

RHEUMATOLOGY  Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241  Indirect and mixed treatment comparisons in arthritis

RHEUMATOLOGY Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis

DocID: 1pLt5 - View Document

JUNE 2016 TABLE OF CONTENTS  INTRODUCTION

JUNE 2016 TABLE OF CONTENTS INTRODUCTION

DocID: 1pshE - View Document